Frolich L

References (14)

Title : Brain health services for the secondary prevention of cognitive impairment and dementia: Opportunities, challenges, and the business case for existing and future facilities - Frisoni_2025_J.Prev.Alzheimers.Dis__100098
Author(s) : Frisoni GB , Ribaldi F , Allali G , Bieth T , Brioschi Guevara A , Cappa S , Cipolotti L , Frederiksen KS , Georges J , Jessen F , Koch G , Masters H , Mendes AJ , Frolich L , Garibotto V , Grau-Rivera O , Pozzi FE , Religa D , Rostamzadeh A , Shallcross L , Shenkin SD , van der Flier WM , Vernooij MW , Visser LNC , Cummings JL , Scheltens P , Dubois B , Moro E , Bassetti CLA , Kivipelto M
Ref : J Prev Alzheimers Dis , :100098 , 2025
Abstract :
PubMedSearch : Frisoni_2025_J.Prev.Alzheimers.Dis__100098
PubMedID: 40102145

Title : The Use and Understanding of Mild Cognitive Impairment in Routine Specialist Care: A Survey Among German Memory Clinics - Benson_2025_Geriatrics.(Basel)_10_
Author(s) : Benson GS , Bartels C , Stamatis F , Belz M , Esselmann H , Frolich L , Hausner L
Ref : Geriatrics (Basel) , 10 : , 2025
Abstract :
PubMedSearch : Benson_2025_Geriatrics.(Basel)_10_
PubMedID: 39997520

Title : Management of mild cognitive impairment (MCI): The need for national and international guidelines - Kasper_2020_World.J.Biol.Psychiatry__1
Author(s) : Kasper S , Bancher C , Eckert A , Forstl H , Frolich L , Hort J , Korczyn AD , Kressig RW , Levin O , Palomo MSM
Ref : World J Biological Psychiatry , :1 , 2020
Abstract :
PubMedSearch : Kasper_2020_World.J.Biol.Psychiatry__1
PubMedID: 32019392

Title : Evaluation of the efficacy, safety and tolerability of orally administered BI 409306, a novel phosphodiesterase type 9 inhibitor, in two randomised controlled phase II studies in patients with prodromal and mild Alzheimer's disease - Frolich_2019_Alzheimers.Res.Ther_11_18
Author(s) : Frolich L , Wunderlich G , Thamer C , Roehrle M , Garcia M, Jr. , Dubois B
Ref : Alzheimers Res Ther , 11 :18 , 2019
Abstract :
PubMedSearch : Frolich_2019_Alzheimers.Res.Ther_11_18
PubMedID: 30755255

Title : Correlation of CSF- and MRI-Biomarkers and Progression of Cognitive Decline in an Open Label MCI Trial - Joachim_2018_J.Prev.Alzheimers.Dis_5_202
Author(s) : Joachim LK , Frolich L , Ruther E , Wiltfang J , Maier W , Kornhuber J , Bauer C , Heuser I , Peters O
Ref : J Prev Alzheimers Dis , 5 :202 , 2018
Abstract :
PubMedSearch : Joachim_2018_J.Prev.Alzheimers.Dis_5_202
PubMedID: 29972214

Title : Insights into globalization: comparison of patient characteristics and disease progression among geographic regions in a multinational Alzheimer's disease clinical program - Cummings_2018_Alzheimers.Res.Ther_10_116
Author(s) : Cummings JL , Atri A , Ballard C , Boneva N , Frolich L , Molinuevo JL , Raket LL , Tariot PN
Ref : Alzheimers Res Ther , 10 :116 , 2018
Abstract :
PubMedSearch : Cummings_2018_Alzheimers.Res.Ther_10_116
PubMedID: 30474567

Title : Effect of Idalopirdine as Adjunct to Cholinesterase Inhibitors on Change in Cognition in Patients With Alzheimer Disease: Three Randomized Clinical Trials - Atri_2018_JAMA_319_130
Author(s) : Atri A , Frolich L , Ballard C , Tariot PN , Molinuevo JL , Boneva N , Windfeld K , Raket LL , Cummings JL
Ref : Jama , 319 :130 , 2018
Abstract :
PubMedSearch : Atri_2018_JAMA_319_130
PubMedID: 29318278

Title : Cholinesterase inhibitor treatment in patients with delirium -
Author(s) : Frolich L , Forstl H
Ref : Lancet , 377 :899\; author reply 901 , 2011
PubMedID: 21397755

Title : Drug profile: transdermal rivastigmine patch in the treatment of Alzheimer disease - Emre_2010_CNS.Neurosci.Ther_16_246
Author(s) : Emre M , Bernabei R , Blesa R , Bullock R , Cunha L , Daniels H , Dziadulewicz E , Forstl H , Frolich L , Gabryelewicz T , Levin O , Lindesay J , Martinez-Lage P , Monsch A , Tsolaki M , van Laar T
Ref : CNS Neurosci Ther , 16 :246 , 2010
Abstract :
PubMedSearch : Emre_2010_CNS.Neurosci.Ther_16_246
PubMedID: 20370805

Title : IDEAL: a 6-month, double-blind, placebo-controlled study of the first skin patch for Alzheimer disease - Winblad_2007_Neurology_69_S14
Author(s) : Winblad B , Grossberg G , Frolich L , Farlow M , Zechner S , Nagel J , Lane R
Ref : Neurology , 69 :S14 , 2007
Abstract :
PubMedSearch : Winblad_2007_Neurology_69_S14
PubMedID: 17646619

Title : The practice of obtaining approval from medical research ethics committees: a comparison within 12 European countries for a descriptive study on acetylcholinesterase inhibitors in Alzheimer's dementia - Rikkert_2005_Eur.J.Neurol_12_212
Author(s) : Rikkert MG , Lauque S , Frolich L , Vellas B , Dekkers W
Ref : Eur Journal of Neurology , 12 :212 , 2005
Abstract :
PubMedSearch : Rikkert_2005_Eur.J.Neurol_12_212
PubMedID: 15693811

Title : Combination therapy in Alzheimer's disease: a review of current evidence - Schmitt_2004_CNS.Drugs_18_827
Author(s) : Schmitt B , Bernhardt T , Moeller HJ , Heuser I , Frolich L
Ref : CNS Drugs , 18 :827 , 2004
Abstract :
PubMedSearch : Schmitt_2004_CNS.Drugs_18_827
PubMedID: 15521788

Title : Treatment with donepezil in Alzheimer patients with and without cerebrovascular disease - Frolich_2002_J.Neurol.Sci_203-204_137
Author(s) : Frolich L , Klinger T , Berger FM
Ref : Journal of Neurology Sci , 203-204 :137 , 2002
Abstract :
PubMedSearch : Frolich_2002_J.Neurol.Sci_203-204_137
PubMedID: 12417372

Title : Changes in pyruvate dehydrogenase complex (PDHc) activity and [3H]QNB-receptor binding in rat brain subsequent to intracerebroventricular injection of bromopyruvate - Frolich_1990_J.Neural.Transm.Park.Dis.Dement.Sect_2_169
Author(s) : Frolich L , Strauss M , Kornhuber J , Hoyer S , Sorbi S , Riederer P , Amaducci L
Ref : J Neural Transm Park Dis Dement Sect , 2 :169 , 1990
Abstract :
PubMedSearch : Frolich_1990_J.Neural.Transm.Park.Dis.Dement.Sect_2_169
PubMedID: 2257058